Zevra Therapeutics (ZVRA) Return on Equity [ROE] (2021 - 2026)
Zevra Therapeutics' Return on Equity [ROE] came in at 34.17% for Q3 2026, up 5.96 percentage points from 28.22% a year earlier and up 6.66 percentage points from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Zevra Therapeutics' Return on Equity [ROE] was 85.66%, up 293.50 percentage points from FY2024.
- Return on Equity [ROE] carries a four-year change of +134.20 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -207.84% in FY2024 (-140.61 pp), -67.23% in FY2023 (-36.94 pp), -30.29% in FY2022 (+18.25 pp) and -48.54% in FY2021.
- The five-year range for quarterly Return on Equity [ROE] is -228.01% (Q1 2025) to 68.92% (Q1 2026).
- Year-over-year, Return on Equity [ROE] has increased for six consecutive quarters, with an average year-over-year change of +86.52 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2026 (a gain of 296.93 percentage points), and the weakest in Q3 2024 (a drop of 141.49 percentage points).
- Business Quant data shows ZVRA's Return on Equity [ROE] at 27.52% (Q2 2026), 68.92% (Q1 2026) and 57.83% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 34.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 34.17% |
| Jun 30, 2026 | 27.52% |
| Mar 31, 2026 | 68.92% |
| Dec 31, 2025 | 57.83% |
| Sep 30, 2025 | 28.22% |
| Jun 30, 2025 | 3.34% |
| Mar 31, 2025 | -228.01% |
| Dec 31, 2024 | -192.83% |
| Sep 30, 2024 | -175.39% |
| Jun 30, 2024 | -164.35% |
| Mar 31, 2024 | -89.36% |
| Dec 31, 2023 | -74.64% |
| Sep 30, 2023 | -33.90% |
| Jun 30, 2023 | -28.20% |
| Mar 31, 2023 | -56.74% |
| Dec 31, 2022 | -31.70% |
| Sep 30, 2022 | -36.50% |
| Jun 30, 2022 | -27.52% |
| Mar 31, 2022 | -0.11% |
| Dec 31, 2021 | -7.33% |
API Access
Zevra Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();